Ascelia Pharma AB

ACE NPV
Create an alert
Sell0.56 SEK
Buy0.57 SEK
0.00 SEK (0.18%)
Last updated today at 12:47 UTC
Trade

Key metrics

Open0.56 SEK
Previous close0.57 SEK
Market capSEK 76.12m
P/E ratio-
Volume163,510
Dividend yield0.00%
EMS-

Company information

Ascelia Pharma AB is a Sweden-based pharmaceutical company focused on the development of novel oncology therapies. The Company identifies, acquires and develops differentiated, underappreciated and derisked ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue126.87m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 111.94m
Total liabilitiesSEK 12.47m
Net debt-SEK 48.89m

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.